Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A Systematic Review of Patients' Perspectives on the Subcutaneous Route of Medication Administration.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Alerted microglia and the sympathetic nervous system: a novel form of microglia in the development of hypertension.
The role of sphingosine 1-phosphate in immunity and sepsis.
No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis.
[Demyelinating diseases in children with acute neurological symptoms].
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
Involvement of Notch1 inhibition in serum-stimulated glia and oligodendrocyte differentiation from human mesenchymal stem cells.
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study.
Micro RNA-155 participates in re-activation of encephalitogenic T cells.
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
Antibodies to aquaporin-1 are not present in neuromyelitis optica.
UNUSUAL CLINICAL CASES THAT MIMIC ACUTE DISSEMINATED ENCEPHALOMYELITIS.
Common gut microbe could help prevent development of multiple sclerosis.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis.
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.
Immunity and inflammation in neurodegenerative diseases.
The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.

Pages